Dergiler / Türk Biyokimya Dergisi / 2021 / Cilt: 46 - Sayı: 2

Mutations in the SARS CoV-2 spike protein may cause functional changes in the protein quaternary structure

SARS CoV-2 spike proteinindeki mutasyonlar, protein kuaterner yapısında fonksiyonel değişikliklere neden olabilir

Sayfa
137–144
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusions: It has been considered that SARS CoV-2 S glycoprotein mutations may cause changes in a protein functional structure that can affect the severity of disease.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: This study aimed to model the changes result ing from mutations in surface (spike/S) glycoproteins, which play a key role in the entry of the severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) into host cells, in a protein quaternary structure and to evaluate their possible effects on the functional structure.
📊
Temel Bulgular & Veri:Methods: Genome sequence information of SARS CoV 2-infected patients located in Turkey was obtained from the GISAID EpiCoV database.
💡
Sonuç & Katkı:Conclusions: It has been considered that SARS CoV-2 S glycoprotein mutations may cause changes in a protein functional structure that can affect the severity of disease.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: This study aimed to model the changes result ing from mutations in surface (spike/S) glycoproteins, which play a key role in the entry of the severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) into host cells, in a protein quaternary structure and to evaluate their possible effects on the functional structure. Methods: Genome sequence information of SARS CoV 2-infected patients located in Turkey was obtained from the GISAID EpiCoV database. Structural analysis of spike proteins was done using bioinformatics tools (MAFFT, PSIPRED, ProMod3, PyMoL and DynOmics). Results: We identified 76 Thr>Ile mutations in the N-ter minal domain; 468 Ile>Val mutations in the receptor bind ing site and 614 Asp>Gly, 679 Asn>Lys, 771 Ala>Val and 772 Val>Ile mutations in the S1 subunit. It has been observed that the mutations, except those of residues 771 and 772, may cause significant conformational, topological and electro static changes in a protein quaternary structure. It has been determined that the mutations in the receptor binding site transform the protein structure into a formation that can mask the binding site and affect receptor affinity. Conclusions: It has been considered that SARS CoV-2 S glycoprotein mutations may cause changes in a protein functional structure that can affect the severity of disease.

Abstract

Amaç: Bu çalışmada, şiddetli akut solunum sendromu koronavirüsü-2′nin (SARS CoV-2) konakçı hücrelere giri şinde anahtar rol oynayan yüzey (spike/S) glikoproteini, mutasyonların proteinin kuaterner ve fonksiyonel yapısı üzerindeki olası etkilerini değerlendirmek amacı ile modellendi. Gereç ve yöntem: Türkiye’de yerleşik SARS CoV-2 ile enfekte hastaların genom sekans bilgileri GISAID EpiCoV veri tabanından elde edildi. Spike proteinlerin yapısal ana lizi biyoinformatik araçlar (MAFFT, PSIPRED, ProMod3, PyMoL ve DynOmics) kullanılarak yapıldı. Tartışma: N-terminal bölgesinde 76 Thr>Ile, reseptör bağ lanma bölgesinde 468 Ile>Val, S1 alt biriminde 614 Asp>Gly, 679 Asn>Lys, 771 Ala>Val ve 772 Val>Ile mutasyonlarını tanımladık. 771 ve 772 rezidüleri dışındaki mutasyonların, protein kuaterner yapısında önemli konformasyonel, topo lojik ve elektrostatik değişikliklere neden olabileceği göz lenmiştir. Reseptör bağlanma bölgesindeki mutasyonların, protein yapısını, bağlanma sahasını maskeleyebilecek ve reseptör afinitesini etkileyebilecek bir formasyona dönüştürdüğü belirlenmiştir. Sonuç: SARS CoV-2 S glikoprotein mutasyonlarının, pro tein fonksiyonel yapısında hastalık şiddetini etkileyebile cek değişikliklere neden olabileceği düşünülmektedir.

🔖

Bu Makaleye Atıf Yap

AKBULUT, E. (2021). Mutations in the SARS CoV-2 spike protein may cause functional changes in the protein quaternary structure. Türk Biyokimya Dergisi, Cilt: 46 - Sayı: 2, 137–144. https://ajindex.com/articles/394974

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (17)

  1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China 2019. N Engl J Med 2020;382:727–33
  2. Worldometer. Coronavirus cases. https://www.worldometers. info/coronavirus/? [accessed June 2020]
  3. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020;367:1444–8
  4. Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med 2020;26:450–2
  5. Ye ZW, Yuan S, Yuen KS, Fung SY, Chan CP, Jin DY, et al. Zoonotic origins of human coronaviruses. Int J Biol Sci 2020;16: 1686–97
  6. Wu F, Zhao S, Yu B, Chen YM, Wang W, Hu Y, et al. Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan China. BioRxiv 2020; 1:1–32
  7. Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 2020;11:1–12
  8. Zhou P, Lou YX, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nat Nat Res 2020;579:270–3
  9. Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 2020;581:215–20
  10. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol Am Soc Microbiol 2020;94:1–9
  11. PubChem. https://pubchem.ncbi.nlm.nih.gov/#query=covid-19 [accessed June 2020]
  12. Cheng F, Murray JL, Rubin DH. Drug repurposing: new treatments for Zika virus infection?. Trends Mol Med 2016;22:919–21
  13. Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov 2020;6:1–18
  14. Zumla A, Chan JFW, Azhar EI, Hui DS, Yuen KY. Coronaviruses-drug discovery and therapeutic options. Nat Rev Drug Discov 2016;15: 327–47
  15. GISAID. Next hCoV-19 app. Genomic epidemiology of hCoV-19. https://www.gisaid.org/epiflu-applications/next-hcov-19-app/ [accessed June 2020]
  16. Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 2018;35:1547–9
  17. NCBI. Surface glycoprotein [Severe acute respiratory syndrome coronavirus 2] - Protein. https://www.ncbi.nlm